KR102653830B1 - Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract - Google Patents
Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract Download PDFInfo
- Publication number
- KR102653830B1 KR102653830B1 KR1020230194438A KR20230194438A KR102653830B1 KR 102653830 B1 KR102653830 B1 KR 102653830B1 KR 1020230194438 A KR1020230194438 A KR 1020230194438A KR 20230194438 A KR20230194438 A KR 20230194438A KR 102653830 B1 KR102653830 B1 KR 102653830B1
- Authority
- KR
- South Korea
- Prior art keywords
- ultraviolet rays
- extract
- aloe arborescens
- fermentation
- composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 25
- 208000024963 hair loss Diseases 0.000 title claims abstract description 25
- 210000004761 scalp Anatomy 0.000 title claims abstract description 25
- 230000007794 irritation Effects 0.000 title claims abstract description 22
- 230000003752 improving hair Effects 0.000 title claims abstract description 19
- 235000011399 aloe vera Nutrition 0.000 title description 9
- 241001116389 Aloe Species 0.000 title description 7
- 240000007474 Aloe arborescens Species 0.000 claims abstract description 81
- 235000004509 Aloe arborescens Nutrition 0.000 claims abstract description 81
- 210000004027 cell Anatomy 0.000 claims abstract description 45
- 230000000694 effects Effects 0.000 claims abstract description 39
- 230000002500 effect on skin Effects 0.000 claims abstract description 21
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 230000030833 cell death Effects 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- 230000034994 death Effects 0.000 claims abstract description 4
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 4
- 238000000855 fermentation Methods 0.000 claims description 79
- 230000004151 fermentation Effects 0.000 claims description 79
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 239000001888 Peptone Substances 0.000 claims description 11
- 108010080698 Peptones Proteins 0.000 claims description 11
- 235000019319 peptone Nutrition 0.000 claims description 11
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 230000037373 wrinkle formation Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000002609 medium Substances 0.000 description 19
- 230000003078 antioxidant effect Effects 0.000 description 17
- 239000003963 antioxidant agent Substances 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 15
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 108010035532 Collagen Proteins 0.000 description 12
- 102000008186 Collagen Human genes 0.000 description 12
- 229920001436 collagen Polymers 0.000 description 12
- 230000002000 scavenging effect Effects 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 229930003935 flavonoid Natural products 0.000 description 9
- 150000002215 flavonoids Chemical class 0.000 description 9
- 235000017173 flavonoids Nutrition 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 229940041514 candida albicans extract Drugs 0.000 description 8
- 239000012138 yeast extract Substances 0.000 description 8
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 230000003676 hair loss Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- VQVUBYASAICPFU-UHFFFAOYSA-N (6'-acetyloxy-2',7'-dichloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Cl)=C(OC(C)=O)C=C1OC1=C2C=C(Cl)C(OC(=O)C)=C1 VQVUBYASAICPFU-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 231100000263 cytotoxicity test Toxicity 0.000 description 4
- 239000012470 diluted sample Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 231100000002 MTT assay Toxicity 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 244000242092 Aloe saponaria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 231100000991 Reactive Oxygen Species (ROS) Photosafety Assay Toxicity 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 244000101643 Aloe ferox Species 0.000 description 1
- 235000015858 Aloe ferox Nutrition 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- -1 aluminum ions Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2102—Aloe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물에 관한 것으로서, 알로에 아보레센스 발효 추출물을 유효성분으로 함유함으로써 자외선에 의한 주름 생성 억제 효과, 자외선에 의한 모유두 세포 및 섬유아세포의 사멸 방지 효과, 자외선에 의한 세포 사멸 및 ROS 생성을 억제하는 효과가 탁월하여 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 기능성 조성물, 화장품 또는 식품 조성물로 활용할 수 있다.The present invention relates to a composition for improving hair loss or scalp irritation caused by ultraviolet rays, which contains fermented extract of Aloe arborescens as an active ingredient. By containing fermented extract of Aloe arborescens as an active ingredient, it has the effect of suppressing wrinkle formation caused by ultraviolet rays, It has an excellent effect of preventing the death of dermal papilla cells and fibroblasts, and of suppressing cell death and ROS production caused by ultraviolet rays, so it can be used as a functional composition, cosmetic or food composition that shows the effect of improving hair loss or scalp irritation caused by ultraviolet rays.
Description
본 발명은 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물에 관한 것으로, 더욱 구체적으로는 알로에 아보레센스(Aloe arborescens) 유산균 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물 및 이를 제조하는 방법에 관한 것이다.The present invention relates to a composition for improving hair loss or scalp irritation caused by ultraviolet rays, and more specifically, to a composition for improving hair loss or scalp irritation caused by ultraviolet rays containing the fermented extract of Aloe arborescens lactic acid bacteria as an active ingredient, and the preparation thereof. It's about how to do it.
알로에는 백합과(Liliaceae) 알로에속(Aloineae)에 속하는 다년생 상록 다육질 초본으로 분류되며, 아프리카 야생에 널리 분포되어 있던 토착 식물이었으나, 현재는 전 세계적으로 분포되어 있다. 알로에 종류는 400여 가지로 분류되며, 알로에 베라(Aloe vera), 알로에 아보레센스(Aloe arborescens), 알로에 사포나리아(Aloe saponaria), 알로에 페록스(Aloe ferox)는 식용으로 쓸 수 있는 대표적인 알로에 종류이다. 알로에 베라는 변비 해소, 위장 강화, 상처 치료 효과 등이 알려져 있으며, 알로에 아보레센스는 혈액순환 촉진, 혈관 개선, 피부재생, 심장 기능 항진 등의 효과가 알려져 있으며, 알로에 사포나리아는 면역력 증강 효과, 알로에 페록스는 항암, 상처 치료, 관절염 완화 효과 등이 알려져 있다.Aloe is classified as a perennial evergreen fleshy herb belonging to the genus Aloineae of the Liliaceae family. It was an indigenous plant widely distributed in the wilds of Africa, but is now distributed worldwide. Aloe types are classified into over 400 types, and Aloe vera, Aloe arborescens, Aloe saponaria, and Aloe ferox are representative types of aloe that can be used for food. am. Aloe vera is known to relieve constipation, strengthen the stomach, and heal wounds. Aloe arborescens is known to promote blood circulation, improve blood vessels, skin regeneration, and enhance heart function. Aloe saponaria has an immunity-boosting effect, and aloe Ferrox is known for its anti-cancer, wound healing, and arthritis-relieving effects.
알로에 아보레센스와 관련된 종래기술로서 한국공개특허 제2010-0064120호에는 변비 개선 및 예방기능을 갖는 식품 조성물이 개시되어 있으며, 한국등록특허 제10-1764131호에는 피부 보습, 피부 탄력 증강, 주름 및 혈행 개선, 셀룰라이트 분해 등의 효과를 가지는 알로에 추출물 및 캡사이신을 유효성분으로 함유하는 피부 외용제 조성물이 개시되어 있다.As a prior art related to Aloe arborescens, Korean Patent Publication No. 2010-0064120 discloses a food composition with the function of improving and preventing constipation, and Korean Patent No. 10-1764131 discloses skin moisturizing, skin elasticity enhancement, wrinkle and blood circulation. A skin external composition containing aloe extract and capsaicin as active ingredients, which has effects such as improving and decomposing cellulite, is disclosed.
알로에 아보레센스의 항산화 활성을 이용하여 산화적 스트레스로부터의 세포를 보호하는 효과, 피부재생, 탄력 촉진 및 상처 치유 효과가 알려져 있으며, 알로에 아보레센스 추출물의 항진균 및 항염증 효과와 관련하여 Trichophyton mentagrophytes의 증식을 효과적으로 억제하는 항진균 효과 연구(Fujita K et al., Antimicrob Agents Chemother, 14(1): 132-6, 1978) 및 항염증 효과 연구(Masatoshi YM et al., Agric Biol Chem, 1627-1629, 1991)가 보고되었다.The antioxidant activity of Aloe arborescens is known to protect cells from oxidative stress, promote skin regeneration, promote elasticity, and heal wounds, and is associated with the proliferation of Trichophyton mentagrophytes in relation to the antifungal and anti-inflammatory effects of Aloe arborescens extract. Research on antifungal effects that effectively inhibits ) was reported.
자외선은 그 파장 영역에 따라 장파장 자외선 (UVA, 320~400nm), 중파장 자외선 (UVB, 200~280nm) 및 단파장 자외선 (UVC, 200~280nm)으로 나눌 수 있으며, 이러한 자외선들은 피부에 여러 손상을 유발한다. UVC은 인체에 매우 유해하나 현재까지는 대기 중의 오존층에 흡수되어 지표상에는 거의 도달하지 않으므로, 주로 UVA와 UVB가 피부에 손상을 유발한다. 에너지가 UVA보다 더 큰 중파장 자외선인, UVB는 일광화상(홍반, 수포 유발), 피부암, 색소 침착, 피부 단백질 변성 및 피부 세포 각질화 촉진 등의 피부 손상을 일으키는 것으로 알려져 있다.Depending on the wavelength range, ultraviolet rays can be divided into long-wavelength ultraviolet rays (UVA, 320-400nm), mid-wavelength ultraviolet rays (UVB, 200-280nm), and short-wavelength ultraviolet rays (UVC, 200-280nm). These ultraviolet rays cause various damage to the skin. cause. UVC is very harmful to the human body, but until now it is absorbed by the ozone layer in the atmosphere and rarely reaches the earth's surface, so UVA and UVB mainly cause damage to the skin. UVB, a mid-wavelength ultraviolet ray with greater energy than UVA, is known to cause skin damage such as sunburn (causing erythema and blisters), skin cancer, pigmentation, skin protein denaturation, and acceleration of skin cell keratinization.
상기 알로에 아보레센스 추출물의 효과에 대한 여러 연구결과들이 보고되었으나, 알로에 아보레센스 발효 추출물을 이용한 자외선으로 인한 탈모 억제 또는 두피 자극 개선 효능 등에 관한 연구는 미비한 실정이다.Although several research results have been reported on the effects of the Aloe arborescens extract, there is a lack of research on the effectiveness of using the Aloe arborescens fermented extract to suppress hair loss caused by ultraviolet rays or improve scalp irritation.
이에 본 발명자들은 알로에 아보레센스 발효 추출물을 이용한 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 기능성 조성물을 개발하고 본 발명을 완성하였다.Accordingly, the present inventors developed a functional composition that shows the effect of improving hair loss or scalp irritation caused by ultraviolet rays using a fermented extract of Aloe arborescens and completed the present invention.
상기한 배경기술로서 설명된 사항들은 본 발명의 배경에 대한 이해증진을 위한 것일 뿐, 이 기술분야에서 통상의 지식을 가진 자에게 이미 알려진 종래기술에 해당함을 인정하는 것으로 받아들여져서는 안 될 것이다.The matters described above as background technology are only for the purpose of improving understanding of the background of the present invention, and should not be taken as admission that they correspond to prior art already known to those skilled in the art.
상기한 종래기술의 문제점을 해결하기 위하여, 본 발명은 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 기능성 조성물을 제공하는 것을 목적으로 한다.In order to solve the problems of the prior art described above, the purpose of the present invention is to provide a functional composition containing fermented extract of Aloe arborescens as an active ingredient and showing the effect of improving hair loss or scalp irritation caused by ultraviolet rays.
또한, 본 발명은 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 화장료 조성물을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a cosmetic composition containing a fermented extract of Aloe arborescens as an active ingredient and showing an effect of improving hair loss or scalp irritation caused by ultraviolet rays.
또한, 본 발명은 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 식품 조성물을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a food composition containing a fermented extract of Aloe arborescens as an active ingredient and showing the effect of improving hair loss or scalp irritation caused by ultraviolet rays.
본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명, 청구범위 및 도면에 의해 더욱 명확하게 된다.Other objects and advantages of the present invention will become more apparent from the following detailed description, claims, and drawings.
상기한 기술적 과제를 해결하기 위하여, 본 발명에서는 본 발명은 알로에 아보레센스 발효 추출물을 이용한 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 기능성 조성물을 제공한다.In order to solve the above technical problems, the present invention provides a functional composition that shows the effect of improving hair loss or scalp irritation caused by ultraviolet rays using a fermented extract of Aloe arborescens.
본 발명에서, 상기 조성물의 발효 배지는 알로에 아보레센스(Aloe arborescens) 에탄올 추출물을 포도당, 펩톤 및 효모 추출물로 구성된 발효 배지에 첨가하여 발효할 수 있으며, 바람직하게는 알로에 아보레센스(Aloe arborescens) 70% 에탄올 추출물을 포도당 0 내지 4 g/L, 펩톤 0 내지 4 g/L 및 효모 추출물 0 내지 1 g/L 농도로 구성된 발효 배지에 첨가하여 발효할 수 있으며, 더욱 바람직하게는 알로에 아보레센스(Aloe arborescens) 70% 에탄올 추출물을 포도당 2.63 g/L 및 펩톤 4.0 g/L 농도로 구성된 발효 배지에 첨가하여 발효할 수 있다.In the present invention, the fermentation medium of the composition can be fermented by adding an ethanol extract of Aloe arborescens to a fermentation medium consisting of glucose, peptone, and yeast extract, preferably 70% of Aloe arborescens. The ethanol extract can be fermented by adding it to a fermentation medium consisting of 0 to 4 g/L of glucose, 0 to 4 g/L of peptone, and 0 to 1 g/L of yeast extract, more preferably Aloe arborescens. ) 70% ethanol extract can be fermented by adding it to a fermentation medium consisting of a concentration of 2.63 g/L glucose and 4.0 g/L peptone.
본 발명의 일실시예로서, 상기 조성물의 발효는 유산균 발효일 수 있으며, 바람직하게는 Lacticaseibacillus rhamnosus 균주를 이용한 발효일 수 있으며, 24시간 동안 37℃에서 발효할 수 있다.As an embodiment of the present invention, the fermentation of the composition may be a lactic acid bacteria fermentation, preferably using a Lacticaseibacillus rhamnosus strain, and may be fermented at 37° C. for 24 hours.
본 발명의 일실시예로서, 상기 알로에 아보레센스 발효 추출물은 자외선에 의한 모유두 세포 및 섬유아세포의 사멸을 방지함으로써 탈모 억제 또는 두피 자극 개선 효능을 나타내는 기능성 조성물일 수 있으며, 바람직하게는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물일 수 있다.As an embodiment of the present invention, the fermented extract of Aloe arborescens may be a functional composition that exhibits the effect of suppressing hair loss or improving scalp stimulation by preventing the death of dermal papilla cells and fibroblasts caused by ultraviolet rays, and preferably, prevents hair loss caused by ultraviolet rays. Alternatively, it may be a composition for improving scalp irritation.
본 발명의 일실시예로서, 상기 알로에 아보레센스 발효 추출물은 자외선에 의한 세포 사멸 및 ROS 생성을 억제하는 효과를 나타내는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물일 수 있다.As an embodiment of the present invention, the fermented extract of Aloe arborescens may be a composition for improving hair loss or scalp irritation caused by ultraviolet rays, which has the effect of suppressing cell death and ROS generation caused by ultraviolet rays.
본 발명의 일실시예로서, 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 화장료 조성물 또는 식품 조성물일 수 있다.As an embodiment of the present invention, it may be a cosmetic composition or food composition that contains fermented extract of Aloe arborescens as an active ingredient and shows the effect of improving hair loss or scalp irritation caused by ultraviolet rays.
본 발명은 기존과 차별화된 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물에 관한 것으로서, 알로에 아보레센스 발효 추출물을 유효성분으로 함유함으로써 자외선에 의한 주름 생성 억제 효과, 자외선에 의한 모유두 세포 및 섬유아세포의 사멸 방지 효과, 자외선에 의한 세포 사멸 및 ROS 생성을 억제하는 효과가 탁월하여 자외선으로 인한 탈모 또는 두피 자극 개선 효과를 나타내는 기능성 조성물, 화장품 또는 식품 조성물로 활용할 수 있다.The present invention relates to a composition for improving hair loss or scalp irritation caused by ultraviolet rays, which is different from the existing composition. By containing fermented extract of Aloe arborescens as an active ingredient, it has an effect of suppressing the formation of wrinkles caused by ultraviolet rays and the death of dermal papilla cells and fibroblasts by ultraviolet rays. It has an excellent prevention effect and an effect of suppressing cell death and ROS generation caused by ultraviolet rays, so it can be used as a functional composition, cosmetic or food composition that shows the effect of improving hair loss or scalp irritation caused by ultraviolet rays.
도 1은 본 발명에 따른 알로에 아보레센스 추출물의 최적 발효조건을 확립하기 위한 표면반응분석결과를 나타낸 것이다(A: glucose, B: peptone, C: yeast extract).
도 2는 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 DPPH 소거능을 이용한 항산화능 측정결과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 3은 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 ABTS 소거능을 이용한 항산화능 측정결과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 4는 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 폴리페놀 함량 측정결과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 5는 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 플라보노이드 함량 측정결과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 6은 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 CCD-986sk에 대한 세포 독성 측정결과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 7은 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 CCD-986sk에 대한 콜라겐 분해 억제 효과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 8은 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 Human Follicle Dermal Papilla Cell에 대한 세포 독성 측정결과(MTT assay)를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 9는 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 Human Follicle Dermal Papilla Cell에 대한 자외선에 의한 세포 사멸 방지효과를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).
도 10은 본 발명에 따른 알로에 아보레센스 추출물의 발효 전후의 Human Follicle Dermal Papilla Cell에 대한 세포 내 항산화 측정결과(ROS assay)를 비교분석한 그래프이다(AE: 발효 전, AEF: 발효 후).Figure 1 shows the results of surface reaction analysis to establish optimal fermentation conditions for the Aloe arborescens extract according to the present invention (A: glucose, B: peptone, C: yeast extract).
Figure 2 is a graph comparing the results of measuring antioxidant capacity using DPPH scavenging ability before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 3 is a graph comparing and analyzing the results of antioxidant capacity measurement using ABTS scavenging ability before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 4 is a graph comparing and analyzing the results of polyphenol content measurement before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 5 is a graph comparing and analyzing the results of measuring the flavonoid content before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 6 is a graph comparing and analyzing the cytotoxicity measurement results for CCD-986sk before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 7 is a graph comparing the collagen decomposition inhibition effect on CCD-986sk before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 8 is a graph comparing the cytotoxicity measurement results (MTT assay) on Human Follicle Dermal Papilla Cell before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 9 is a graph comparing and analyzing the effect of preventing cell death caused by ultraviolet rays on Human Follicle Dermal Papilla Cell before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
Figure 10 is a graph comparing and analyzing the intracellular antioxidant measurement results (ROS assay) for Human Follicle Dermal Papilla Cell before and after fermentation of the Aloe arborescens extract according to the present invention (AE: before fermentation, AEF: after fermentation).
이하, 첨부된 도면을 참조로 본 발명의 바람직한 실시예를 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, preferred embodiments of the present invention will be described in more detail with reference to the attached drawings. These examples are only for illustrating the present invention in more detail, and it is understood by those skilled in the art that the scope of the present invention is not limited by these examples according to the gist of the present invention. It will be self-evident.
본 발명의 특징들은 이하의 실시예를 통해서 더욱 명확히 설명될 수 있다. The features of the present invention can be more clearly explained through the following examples.
[실시예 1] 알로에 아보레센스(Aloe arborescens) 발효 추출물 제조[Example 1] Preparation of Aloe arborescens fermented extract
1. 알로에 아보레센스 최적 추출 용매 조건1. Optimal extraction solvent conditions for Aloe arborescens
본 발명에서 알로에 아보레센스의 추출은 0~100% 에탄올을 첨가하여 진행했으며, DPPH 소거능을 이용한 항산화능 측정결과로 최적의 용매 조건을 확인하였다.In the present invention, extraction of Aloe arborescens was carried out by adding 0 to 100% ethanol, and the optimal solvent conditions were confirmed based on the results of antioxidant activity measurement using DPPH scavenging ability.
알로에 아보레센스에 대한 에탄올 농도 별 추출물에 대한 비교는 [표 1]에 나타내었다.A comparison of extracts of Aloe arborescens by ethanol concentration is shown in [Table 1].
DPPH 소거능을 이용한 항산화능 측정에서 다양한 에탄올 농도로 추출한 알로에 아보레센스 추출물을 실험한 결과 감소량을 기준으로 70% 에탄올 추출물이 가장 높은 감소량을 보였다(100%-75.4%=24.6%). 즉 70% 에탄올에서의 추출물이 항산화능이 가장 높아 가장 효과적인 농도는 70% 에탄올이며 이를 최적의 용매 조건으로 확정하였다.In measuring antioxidant capacity using DPPH scavenging ability, Aloe arborescens extracts extracted at various ethanol concentrations were tested and the 70% ethanol extract showed the highest reduction (100%-75.4%=24.6%). That is, the extract in 70% ethanol had the highest antioxidant capacity, so the most effective concentration was 70% ethanol, which was confirmed as the optimal solvent condition.
2. 알로에 아보레센스 최적 발효 조건2. Aloe arborescens optimal fermentation conditions
본 발명에서 알로에 아보레센스의 발효는 상기 알로에 아보레센스 70% 에탄올 추출물에 첨가하는 포도당, 펩톤 및 효모 추출물 농도 범위를 측정하여 설정하였으며, DPPH 소거능 및 플라보노이드를 기준으로 가장 높은 발효 증가율을 보이는 조건을 최적의 발효조건으로 확인하였다.In the present invention, the fermentation of Aloe arborescens was established by measuring the concentration range of glucose, peptone, and yeast extract added to the 70% ethanol extract of Aloe arborescens, and the conditions showing the highest fermentation increase rate were optimized based on DPPH scavenging ability and flavonoids. This was confirmed under fermentation conditions.
본 발명의 일실시예로서, 포도당, 펩톤, 효모 추출물의 농도 범위는 각각 0-4 g/L, 0-4 g/L, 0-1 g/L에서 실시하였다.As an example of the present invention, the concentration ranges of glucose, peptone, and yeast extract were 0-4 g/L, 0-4 g/L, and 0-1 g/L, respectively.
최적의 발효조건을 확인하기 위해, 포도당, 펩톤, 효모 추출물의 농도에 따른 DPPH 소거능 및 플라보노이드 함량은 [표 2]에 나타내었다.To confirm the optimal fermentation conditions, the DPPH scavenging ability and flavonoid content according to the concentrations of glucose, peptone, and yeast extract are shown in [Table 2].
[표 2]에 나타낸 바와 같이, 발효조건 확인에서 다양한 농도의 포도당, 펩톤, 효모 추출물을 첨가한 배지에 알로에 아보레센스 추출물을 넣어 발효시킨 뒤 측정한 결과, DPPH를 기준으로 2 g/L, 4 g/L, 1 g/L에서 가장 높은 발효 증가율을 보였으며, 플라보노이드를 기준으로 2 g/L, 4 g/L, 0 g/L에서 가장 높은 발효 증가율을 보였다.As shown in [Table 2], when confirming the fermentation conditions, Aloe arborescens extract was fermented in a medium containing various concentrations of glucose, peptone, and yeast extract, and the results were measured. Based on DPPH, 2 g/L, 4 The highest fermentation increase rate was seen at g/L and 1 g/L, and based on flavonoids, the highest fermentation increase rate was shown at 2 g/L, 4 g/L, and 0 g/L.
도 1에 나타낸 바와 같이, 상기 결과를 등고선 및 3D 표면도를 통해 표현하였으며, 최적화 결과 Glucose 2.63 g/L, Pepton 4.0 g/L, Yeast extract 0 g/L 조건에서 발효 최적화를 보였다.As shown in Figure 1, the results were expressed through contour lines and 3D surface diagrams, and the optimization results showed that fermentation was optimized under the conditions of Glucose 2.63 g/L, Pepton 4.0 g/L, and Yeast extract 0 g/L.
[실험예 1] 알로에 아보레센스 발효 추출물의 항산화 활성 평가[Experimental Example 1] Evaluation of antioxidant activity of Aloe arborescens fermented extract
DPPH assay 측정DPPH assay measurement
2,2-diphenyl-1-picrylhydrazyl(DPPH) 소거능을 이용하여 항산화능을 측정하는 것으로서, DPPH가 radical 활성 정도에 따라 발색이 바뀌는 것을 이용하여 시료의 항산화능을 측정하였다.Antioxidant ability is measured using the scavenging ability of 2,2-diphenyl-1-picrylhydrazyl (DPPH). The antioxidant ability of the sample was measured using the fact that DPPH changes color depending on the degree of radical activity.
DPPH(Sigma, USA)는 ethanol 70% 용액에 녹여 향후 실험 조건에서 540 nm 파장의 흡광도가 1.0이 되도록 희석하였다. 시료는 ethanol 70% 용액으로 희석하여 다양한 농도의 용액을 제조하였다. 희석된 DPPH 용액 1 mL와 희석 시료 0.2 mL를 혼합한 뒤 20분간 반응시켰다. 반응이 끝난 시료 100 μL를 96 well plate에 옮긴 뒤 microplate reader(synergy HT, Biotek, USA)로 540 nm 파장의 흡광도를 측정하였다.DPPH (Sigma, USA) was dissolved in 70% ethanol solution and diluted so that the absorbance at a wavelength of 540 nm was 1.0 under future experimental conditions. Samples were diluted with 70% ethanol solution to prepare solutions of various concentrations. 1 mL of diluted DPPH solution and 0.2 mL of diluted sample were mixed and reacted for 20 minutes. 100 μL of the reacted sample was transferred to a 96 well plate and the absorbance at a wavelength of 540 nm was measured using a microplate reader (synergy HT, Biotek, USA).
실험에 앞서 추출 조건의 확인을 위해서 0~100% 에탄올로 추출하여 DPPH의 소거능을 확인하여 가장 소거능이 높았던 70% 에탄올 추출물을 사용하였다.Prior to the experiment, to confirm the extraction conditions, extraction was performed with 0-100% ethanol to confirm the scavenging ability of DPPH, and the 70% ethanol extract with the highest scavenging ability was used.
발효는 동결건조를 통해 용매를 제거한 알로에 아보레센스 추출물을 Lacticaseibacillus rhamnosus 균주를 포함하는 유산균 배지에 원 추출물 부피와 동일하게 첨가하여 진행하였다. 균주는 전배양된 배지를 원심분리하여 OD 600 nm에서 0.7이 되도록 증류수로 희석한 다음 1% 농도로 알로에 아보레센스 추출물 첨가 배지에 접종하여, 24시간 동안 37℃에서 배양하였다.Fermentation was carried out by adding the Aloe arborescens extract, from which the solvent had been removed through freeze-drying, into a lactic acid bacteria medium containing the strain Lacticaseibacillus rhamnosus in an amount equal to the volume of the original extract. The strain was centrifuged on the pre-cultured medium, diluted with distilled water to an OD of 0.7 at 600 nm, then inoculated into a medium supplemented with Aloe arborescens extract at a concentration of 1%, and cultured at 37°C for 24 hours.
비교대상(control)으로서 ascorbic acid의 EC50은 215.11±34.46 μg/mL였으며, [표 3]에 나타낸 바와 같이, 발효 전의 알로에 아보레센스 추출물의 EC50은 558.37±64.31 μg/mL이었다.As a control, the EC 50 of ascorbic acid was 215.11 ± 34.46 μg/mL, and as shown in [Table 3], the EC 50 of the Aloe arborescens extract before fermentation was 558.37 ± 64.31 μg/mL.
[표 4]에 나타낸 바와 같이, 본 발명의 일실시예에 따른 발효 후의 알로에 아보레센스 추출물의 EC50은 291.88±35.78 μg/mL로 나타났다.As shown in [Table 4], the EC 50 of the Aloe arborescens extract after fermentation according to an example of the present invention was 291.88 ± 35.78 μg/mL.
도 2에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 DPPH 소거능 변화를 살펴보면, EC50은 동일 항산화능을 내는데 필요한 항산화 물질의 농도로, 작으면 작을수록 강력하다. 발효 전 EC50은 558.37±64.31 μg/mL이며 발효 후 EC50은 291.88±35.78 μg/mL로 약 1.9배 항산화능이 증가하였다.As shown in Figure 2, looking at the change in DPPH scavenging ability of the Aloe arborescens extract before and after fermentation, EC 50 is the concentration of antioxidant substances required to produce the same antioxidant ability, and the smaller it is, the more powerful it is. The EC 50 before fermentation was 558.37 ± 64.31 μg/mL, and the EC 50 after fermentation was 291.88 ± 35.78 μg/mL, which increased the antioxidant capacity by about 1.9 times.
ABTS 소거능을 이용한 항산화능 측정(ABTS assay)Measurement of antioxidant capacity using ABTS scavenging ability (ABTS assay)
ABTS가 radical 활성 정도에 따라 발색이 바뀌는 것을 이용하여 시료의 항산화능을 측정할 수 있다.The antioxidant capacity of a sample can be measured by using the fact that the color of ABTS changes depending on the degree of radical activity.
ABTS (Sigma, USA)는 ethanol 70% 용액에 녹인 뒤, ammonium persulfate를 2.45 mM이 되도록 첨가하여 8시간 발색을 유도한 뒤 향후 실험 조건에서 740 nm 파장의 흡광도가 1.00이 되도록 희석하여 사용하였다. 시료는 ethanol 70% 용액으로 희석하여 다양한 농도의 용액을 제조하였다.ABTS (Sigma, USA) was dissolved in 70% ethanol solution, then ammonium persulfate was added to 2.45 mM to induce color development for 8 hours, and then diluted and used so that the absorbance at 740 nm wavelength was 1.00 under future experimental conditions. Samples were diluted with 70% ethanol solution to prepare solutions of various concentrations.
미리 희석된 ABTS 용액 1 mL와 희석 시료 0.2 mL를 혼합한 뒤 20분간 반응시키고 반응이 끝난 시료 100 μL를 96 well plate에 옮긴 뒤 microplate reader(synergy HT, Biotek, USA)로 740 nm 파장의 흡광도를 측정하여 ABTS radical 소거능을 측정하였다.Mix 1 mL of pre-diluted ABTS solution with 0.2 mL of diluted sample, react for 20 minutes, transfer 100 μL of the reaction sample to a 96 well plate, and measure the absorbance at 740 nm using a microplate reader (synergy HT, Biotek, USA). ABTS radical scavenging ability was measured.
비교대상(control)으로서 ascorbic acid의 EC50은 44.21±7.49 μg/mL였으며, [표 5]에 나타낸 바와 같이, 발효 전의 알로에 아보레센스 추출물의 EC50은 198.76±32.12 μg/mL로 나타났다.As a control, the EC 50 of ascorbic acid was 44.21 ± 7.49 μg/mL, and as shown in [Table 5], the EC 50 of the Aloe arborescens extract before fermentation was 198.76 ± 32.12 μg/mL.
[표 6]에 나타낸 바와 같이, 본 발명의 일실시예에 따른 발효 후의 알로에 아보레센스 추출물의 EC50은 103.40±13.10 μg/mL로 나타났다.As shown in [Table 6], the EC 50 of the Aloe arborescens extract after fermentation according to one embodiment of the present invention was found to be 103.40 ± 13.10 μg/mL.
도 3에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 ABTS 소거능 변화를 살펴보면, 발효 전 EC50은 198.76±32.12 μg/mL이며 발효 후 EC50은 103.40±13.10 μg/mL로 약 1.9배 항산화능이 증가하였다.As shown in Figure 3, looking at the change in ABTS scavenging ability of the Aloe arborescens extract before and after fermentation, the EC 50 before fermentation is 198.76 ± 32.12 μg/mL and the EC 50 after fermentation is 103.40 ± 13.10 μg/mL, which is about 1.9 times antioxidant. ability has increased.
폴리페놀 함량 측정Polyphenol content measurement
Folin-ciocalteu reagent가 폴리페놀에 의한 반응에 의해 발색이 바뀌는 것을 이용하여 시료의 폴리페놀 농도를 측정할 수 있다.The polyphenol concentration of a sample can be measured using the fact that Folin-ciocalteu reagent changes color due to a reaction with polyphenol.
실험에는 Folin-ciocalteu reagent (phenol reagent, Junsei, Japan), 10 % Na2CO3를 사용하였다. Folin-ciocalteu reagent 1 mL와 희석 시료 1 mL를 혼합한 뒤 15분간 반응을 기다렸으며, 10 % Na2CO3 1 mL를 추가로 혼합하여 발색시켰다.Folin-ciocalteu reagent (phenol reagent, Junsei, Japan) and 10% Na 2 CO 3 were used in the experiment. After mixing 1 mL of Folin-ciocalteu reagent and 1 mL of the diluted sample, the reaction was waited for 15 minutes, and 1 mL of 10% Na 2 CO 3 was additionally mixed to develop color.
발색이 끝난 시료 200 μL를 96 well plate에 옮긴 뒤 microplate reader(synergy HT, Biotek, USA)로 740 nm 파장의 흡광도를 측정하였으며, gallic acid standard curve를 바탕으로 환산하였다.After transferring 200 μL of the color-developed sample to a 96 well plate, the absorbance at a wavelength of 740 nm was measured using a microplate reader (synergy HT, Biotek, USA), and converted based on the gallic acid standard curve.
도 4에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 폴리페놀 함량 변화를 살펴보면, 발효 전 폴리페놀의 함량은 9.174±0.289 mg gallic acid/g였으나 발효 후 11.793±0.265 mg gallic acid/g로 나타났다. 이는 약 1.3배 증가한 수치다.As shown in Figure 4, looking at the change in polyphenol content before and after fermentation of the Aloe arborescens extract, the content of polyphenol before fermentation was 9.174 ± 0.289 mg gallic acid / g, but after fermentation it was 11.793 ± 0.265 mg gallic acid / g. appear. This is an increase of approximately 1.3 times.
플라보노이드 함량 측정Flavonoid content determination
Aluminium ion이 플라보노이드와 반응하여 진한 황색을 나타내는 것을 이용하여 시료의 플라보노이드 농도를 측정할 수 있다.The flavonoid concentration of a sample can be measured by using the fact that aluminum ions react with flavonoids and produce a dark yellow color.
실험에 앞서 10 % AlCl3를 제조하였으며 10 % AlCl3 1 mL와 희석 시료 1 mL를 혼합한 뒤 15분간 반응시켰다.Prior to the experiment, 10% AlCl 3 was prepared, and 1 mL of 10% AlCl 3 and 1 mL of the diluted sample were mixed and reacted for 15 minutes.
반응이 끝난 시료 200 μL를 96 well plate에 옮긴 뒤 microplate reader(synergy HT, Biotek, USA)로 450 nm 파장의 흡광도를 측정하여 시료의 플라보노이드 농도를 측정하였다.After transferring 200 μL of the reacted sample to a 96 well plate, the flavonoid concentration of the sample was measured by measuring the absorbance at a wavelength of 450 nm using a microplate reader (synergy HT, Biotek, USA).
결과는 quercetin standard curve를 바탕으로 환산을 실시하였다.The results were converted based on the quercetin standard curve.
도 5에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 폴리페놀 함량 변화를 살펴보면, 발효 전 플라보노이드의 함량은 5.897±0.052 mg quercetin/g였으나 발효 후 7.216±0.170 mg quercetin/g로 나타났다. 이는 약 1.2배 증가한 수치다.As shown in Figure 5, looking at the change in polyphenol content before and after fermentation of the Aloe arborescens extract, the flavonoid content before fermentation was 5.897 ± 0.052 mg quercetin/g, but after fermentation it was 7.216 ± 0.170 mg quercetin/g. This is an increase of approximately 1.2 times.
[실험예 2] 알로에 아보레센스[Experimental Example 2] Aloe Arborescens 추출물의 콜라겐 분해 억제 활성 평가Evaluation of collagen decomposition inhibition activity of extract
CCD-986sk에 대한 세포 독성 측정(MTT assay)Cytotoxicity measurement for CCD-986sk (MTT assay)
NADH 등의 세포 내의 환원성 물질에 의해 MTT가 결정화되는 것을 이용하여 세포의 활성 및 생존율을 측정할 수 있다.The activity and survival rate of cells can be measured using the crystallization of MTT by reducing substances within cells, such as NADH.
본 발명에서 주름 억제 효과를 확인하기 위해 CCD-986sk (한국세포주은행)을 사용하였으며, 실험에 앞서 세포 독성 실험을 진행하였다. 세포 배양 배지로는 DMEM broth (Dulbecco's Modified Eagle Medium, GE healthcare, USA)를 사용하였으며 FBS (fetal bovine serum, Sigma, USA) 5%를 첨가하여 제조, 항생물질로는 Penicillin-Streptomycin (100×) (Sigma, USA)을 사용하여 제조하였다. 알로에 아보레센스 추출물은 0.22 μm syringe filter (whatman, UK)를 통해 제균한 뒤 DMEM broth에 희석하여 처리하였다.In the present invention, CCD-986sk (Korea Cell Line Bank) was used to confirm the anti-wrinkle effect, and a cytotoxicity test was conducted prior to the experiment. DMEM broth (Dulbecco's Modified Eagle Medium, GE healthcare, USA) was used as a cell culture medium, prepared with 5% FBS (fetal bovine serum, Sigma, USA), and Penicillin-Streptomycin (100×) as an antibiotic. It was manufactured using Sigma, USA). Aloe arborescens extract was sterilized through a 0.22 μm syringe filter (whatman, UK) and then diluted in DMEM broth.
먼저 CCD-986sk를 상기 배지를 이용해 전배양한 뒤, trypsin을 이용해 dish에서 떼어낸 뒤, 96 well plate에 well 당 5.0×103 cell을 주입하여 24시간 배양하였다. 세포의 부착이 확인되면 상층액을 제거한 뒤 시료가 포함된 DMEM을 100 μg/mL를 기준으로 다양한 농도로 처리한 뒤 24시간 동안 배양하였다. 배양 후 상층액을 제거하고 MTT 용액(5 mg/mL) 100 μL를 가해준 뒤 온도 37℃, CO2 농도 5% 의 환경에서 3시간 동안 MTT를 결정화시켰다. 그 후 각 well에 생성된 결정이 제거되지 않도록 상층액을 제거한 뒤 결정을 DMSO로 녹여 540 nm 파장에서의 흡광도를 측정하여 세포의 생존율을 계산하였다.First, CCD-986sk was pre-cultured using the above medium, then removed from the dish using trypsin, and then 5.0×10 3 cells per well were injected into a 96 well plate and cultured for 24 hours. When cell attachment was confirmed, the supernatant was removed, and DMEM containing the sample was treated with various concentrations based on 100 μg/mL and cultured for 24 hours. After incubation, the supernatant was removed, 100 μL of MTT solution (5 mg/mL) was added, and MTT was crystallized for 3 hours in an environment of 37°C and 5% CO 2 concentration. Afterwards, the supernatant was removed to prevent the crystals formed in each well from being removed, the crystals were dissolved in DMSO, and the absorbance at a wavelength of 540 nm was measured to calculate the cell survival rate.
[표 7] 및 도 6에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 CCD 986sk의 세포독성 측정결과를 살펴보면, 발효 전과 발효 후 모든 농도 범위에서 80% 이상의 세포 생존을 보인 동시에 농도에 비례한 증가 경향도 약하여 알로에 아보레센스 추출물의 독성이 낮은 것을 확인하였다.As shown in [Table 7] and Figure 6, looking at the cytotoxicity measurement results of CCD 986sk before and after fermentation of the Aloe arborescens extract, cell survival of more than 80% was shown in all concentration ranges before and after fermentation, and the cell survival was proportional to the concentration. The increasing trend was also weak, confirming that the toxicity of Aloe arborescens extract was low.
CCD-986sk에 대한 콜라겐 분해 억제 효과 측정Measurement of collagen degradation inhibition effect on CCD-986sk
UV를 처리한 CCD-986sk가 콜라겐을 분해하는 것을 이용하여 자외선에 의한 손상을 확인할 수 있다.Damage caused by UV rays can be confirmed by using UV-treated CCD-986sk to decompose collagen.
본 발명에서 주름 억제 효과를 확인하기 위해 CCD-986sk (한국세포주은행)을 사용하였으며, 실험에 앞서 세포 독성 실험을 진행하였다. 세포 배양 배지로는 DMEM broth (Dulbecco's Modified Eagle Medium, GE healthcare, USA)를 사용하였으며 FBS (fetal bovine serum, Sigma, USA) 5%를 첨가하여 제조, 항생물질로는 Penicillin-Streptomycin (100×) (Sigma, USA)을 사용하여 제조하였다. 알로에 아보레센스 추출물은 0.22 μm syringe filter (whatman, UK)를 통해 제균한 뒤 DMEM broth에 희석하여 처리하였다.In the present invention, CCD-986sk (Korea Cell Line Bank) was used to confirm the anti-wrinkle effect, and a cytotoxicity test was conducted prior to the experiment. DMEM broth (Dulbecco's Modified Eagle Medium, GE healthcare, USA) was used as a cell culture medium, prepared with 5% FBS (fetal bovine serum, Sigma, USA), and Penicillin-Streptomycin (100×) as an antibiotic. It was manufactured using Sigma, USA). Aloe arborescens extract was sterilized through a 0.22 μm syringe filter (whatman, UK) and then diluted in DMEM broth.
먼저 CCD-986sk를 상기 배지를 이용해 전배양한 뒤, trypsin을 이용해 dish에서 떼어낸 뒤, 96 well plate에 well 당 5.0×103 cell을 주입하여 24시간 배양하였다. 세포의 부착이 확인되면 상층액을 제거한 뒤 시료가 포함된 DMEM을 100 μg/mL를 기준으로 다양한 농도로 처리한 뒤 자외선 20 mJ/cm2를 처리한 뒤 48시간 동안 배양하였다. 배양 후 Procollagen Type I C-peptide (PIP) EIA Kit (Takara)를 이용해 콜라겐 양을 측정하였다.First, CCD-986sk was pre-cultured using the above medium, then removed from the dish using trypsin, and then 5.0×10 3 cells per well were injected into a 96 well plate and cultured for 24 hours. When cell attachment was confirmed, the supernatant was removed, and DMEM containing the sample was treated with various concentrations based on 100 μg/mL, then treated with ultraviolet rays at 20 mJ/cm 2 and cultured for 48 hours. After culturing, the amount of collagen was measured using the Procollagen Type I C-peptide (PIP) EIA Kit (Takara).
[표 8] 및 도 7에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 CCD-986sk의 콜라겐 분해 억제효과를 측정한 결과를 살펴보면, 자외선을 조사하여 콜라겐 분해를 유도하여 진행하였으며, 자외선 조사에 따른 콜라겐 감소가 알로에 아보레센스 발효 추출물 처리시 유의미하게 감소하였다. 이러한 효과는 두피에서는 두피 및 모공의 구조 유지에 영향을 줄 수 있으므로, 두피 자극에 대한 개선 효과로 볼 수 있을 것이다.As shown in [Table 8] and Figure 7, looking at the results of measuring the collagen decomposition inhibition effect of CCD-986sk before and after fermentation of Aloe arborescens extract, collagen decomposition was induced by irradiating ultraviolet rays, and ultraviolet irradiation was performed. The reduction in collagen was significantly reduced when treated with fermented Aloe arborescens extract. Since this effect can affect the maintenance of the structure of the scalp and pores on the scalp, it can be seen as an improving effect on scalp irritation.
콜라겐을 만들어내는 CCD 986sk에 자외선을 조사하여 콜라겐 감소를 유도하였다. 발효 전과 발효 후 모든 농도 범위에서 UV를 조사하였을 때의 감소된 수치인 54.3%보다 높은 콜라겐 양을 생성하였으며, 이는 알로에 아보레센스 추출물이 자외선에 의한 세포의 손상 및 콜라겐 분해를 억제한다는 것을 보여준다. 이때 양측을 비교할 경우 모든 농도에서 알로에 아보레센스 발효 추출물을 처리한 세포가 더 많은 콜라겐을 생성한 것을 보아 발효를 통해 보호효과를 높인 것으로 예상된다.Collagen reduction was induced by irradiating ultraviolet rays to CCD 986sk, which produces collagen. A higher amount of collagen was produced than the reduced value of 54.3% when UV irradiated in all concentration ranges before and after fermentation, showing that Aloe arborescens extract inhibits cell damage and collagen decomposition caused by UV rays. At this time, when comparing the two sides, cells treated with Aloe arborescens fermented extract at all concentrations produced more collagen, so it is expected that the protective effect was increased through fermentation.
[실험예 3] 탈모 억제효과[Experimental Example 3] Hair loss inhibition effect
Human Follicle Dermal Papilla Cell에 대한 세포 독성 측정 (MTT assay)Measurement of cytotoxicity against Human Follicle Dermal Papilla Cell (MTT assay)
NADH 등의 세포 내의 환원성 물질에 의해 MTT가 결정화되는 것을 이용하여 세포의 활성 및 생존율을 측정할 수 있다.The activity and survival rate of cells can be measured using the crystallization of MTT by reducing substances within cells, such as NADH.
본 발명에서 알로에 아보레센스 발효 추출물의 자외선에 대한 모유두 세포 보호 효과를 확인하기 위해 Human Follicle Dermal Papilla Cell (HFDPC, Promocell)을 사용하였으며, 실험에 앞서 세포 독성 실험을 진행하였다. 세포 배양 배지로는 Follicle Dermal Papilla Cell Growth Medium (FDPCG Medium, Promocell)을 사용하였으며 Follicle Dermal Papilla Cell Growth Medium KIT (최종 농도 Fetal Calf Serum 0.04 ml/ml, Bovine Pituitary Extract 0.004 ml/ml, Basic Fibroblast Growth Factor (recombinant human) 1 ng/ml, Insulin (recombinant human) 5 μg/m)를 첨가하여 제조하였다. 알로에 아보레센스 추출물은 0.22 μm syringe filter (whatman, UK)를 통해 제균한 뒤 FDPCG Medium에 희석하여 처리하였다.In the present invention, Human Follicle Dermal Papilla Cell (HFDPC, Promocell) was used to confirm the protective effect of Aloe arborescens fermented extract on dermal papilla cells against ultraviolet rays, and a cytotoxicity test was conducted prior to the experiment. As a cell culture medium, Follicle Dermal Papilla Cell Growth Medium (FDPCG Medium, Promocell) was used, and Follicle Dermal Papilla Cell Growth Medium KIT (final concentration Fetal Calf Serum 0.04 ml/ml, Bovine Pituitary Extract 0.004 ml/ml, Basic Fibroblast Growth Factor (recombinant human) 1 ng/ml, Insulin (recombinant human) 5 μg/m) was added. Aloe arborescens extract was sterilized through a 0.22 μm syringe filter (whatman, UK) and then diluted in FDPCG Medium.
먼저 HFDPC를 상기 배지를 이용해 전배양한 뒤, trypsin를 이용해 dish에서 떼어낸 뒤, 96 well plate에 well 당 1.0×105 cell을 주입하여 24시간 배양하였다. 세포의 부착이 확인되면 상층액을 제거한 뒤 시료가 포함된 FDPCG Medium을 100 μg/mL를 기준으로 다양한 농도로 처리한 뒤 24시간 동안 배양하였다. 배양 후 상층액을 제거하고 MTT 용액(5 mg/mL) 100 μL를 가해준 뒤 온도 37℃, CO2 농도 5% 의 환경에서 3시간 동안 MTT를 결정화시켰다. 그 후 각 well에 생성된 결정이 제거되지 않도록 상층액을 제거한 뒤 결정을 DMSO로 녹여 540 nm 파장에서의 흡광도를 측정하여 세포의 생존율을 계산하였다.First, HFDPC was pre-cultured using the above medium, then removed from the dish using trypsin, and then 1.0×10 5 cells per well were injected into a 96 well plate and cultured for 24 hours. When cell attachment was confirmed, the supernatant was removed, and FDPCG Medium containing the sample was treated with various concentrations based on 100 μg/mL and cultured for 24 hours. After incubation, the supernatant was removed, 100 μL of MTT solution (5 mg/mL) was added, and MTT was crystallized for 3 hours in an environment of 37°C and 5% CO 2 concentration. Afterwards, the supernatant was removed to prevent the crystals formed in each well from being removed, the crystals were dissolved in DMSO, and the absorbance at a wavelength of 540 nm was measured to calculate the cell survival rate.
그 후 동일한 조건으로 자외선을 20 mJ/cm2 세기로 처리하여 24시간 배양하여 자외선 조사에 따른 세포 사멸 방지 효과를 확인하였다.Afterwards, the cells were treated with UV light at an intensity of 20 mJ/ cm2 under the same conditions and cultured for 24 hours to confirm the effect of preventing cell death due to UV irradiation.
HFDPC는 모유두 세포로 모발의 성장에 중요한 역할을 한다. 자외선을 조사하는 경우 세포의 손상으로 인해 세포가 사멸되기도 한다.HFDPC is a dermal papilla cell that plays an important role in hair growth. When irradiated with ultraviolet rays, cells may die due to cell damage.
[표 9] 및 도 8에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 Human Follicle Dermal Papilla Cell에 대한 세포 독성을 측정한 결과를 살펴보면, 발효 전과 발효 후 모든 농도 범위에서 80% 이상의 세포 생존을 보인 동시에 농도에 비례한 증가 경향도 약하여 알로에 아보레센스 추출물의 독성이 낮은 것을 확인하였다.As shown in [Table 9] and Figure 8, looking at the results of measuring the cytotoxicity of the Aloe arborescens extract to Human Follicle Dermal Papilla Cell before and after fermentation, cell survival of more than 80% was observed in all concentration ranges before and after fermentation. At the same time, the tendency to increase in proportion to concentration was weak, confirming that the toxicity of the Aloe arborescens extract was low.
[표 10] 및 도 9에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 자외선 보호효과를 살펴보면, 자외선을 조사하였을 때에도 발효 전과 발효 후 모든 농도 범위에서 UV를 조사하였을 때의 감소된 수치인 59.2%보다 높은 세포 생존율을 보였으며, 이는 알로에 아보레센스 추출물이 자외선에 의한 세포의 사멸을 억제한다는 것을 보여준다. 이때 양측을 비교할 경우 모든 농도에서 알로에 아보레센스 발효 추출물을 처리한 세포가 더 높은 생존율을 보여 발효를 통해 보호효과를 높인 것으로 예상된다.As shown in [Table 10] and Figure 9, looking at the UV protection effect before and after fermentation of the Aloe arborescens extract, even when irradiated with UV rays, the reduced value when irradiated with UV in all concentration ranges before and after fermentation was The cell survival rate was higher than 59.2%, showing that Aloe arborescens extract inhibits cell death caused by ultraviolet rays. At this time, when comparing the two sides, cells treated with fermented Aloe arborescens extract at all concentrations showed a higher survival rate, which is expected to increase the protective effect through fermentation.
Human Follicle Dermal Papilla Cell에 대한 세포 내 항산화 측정(ROS assay)Measurement of intracellular antioxidants in Human Follicle Dermal Papilla Cell (ROS assay)
Human Follicle Dermal Papilla Cell에 UV를 처리할 경우 ROS를 생산하며 2',7'-Dichlorofluescececetate(DCFDA)와 반응하여 형광을 나타내는 것을 이용하여 해당 물질이 염증 과정에서 미치는 영향을 확인할 수 있다.When UV is applied to Human Follicle Dermal Papilla Cell, ROS is produced and the effect of the substance on the inflammatory process can be confirmed by reacting with 2',7'-Dichlorofluescececetate (DCFDA) to produce fluorescence.
본 발명에서 추출물의 자외선에 대한 모유두 세포 보호 효과를 확인하기 위해 Human Follicle Dermal Papilla Cell (HFDPC, Promocell)을 사용하였으며, 실험에 앞서 세포 독성 실험을 진행하였다. 세포 배양 배지로는 Follicle Dermal Papilla Cell Growth Medium (FDPCG Medium, Promocell)을 사용하였으며 Follicle Dermal Papilla Cell Growth Medium KIT (최종 농도 Fetal Calf Serum 0.04 ml/ml, Bovine Pituitary Extract 0.004 ml/ml, Basic Fibroblast Growth Factor (recombinant human) 1 ng/ml, Insulin (recombinant human) 5 μg/m)를 첨가하여 제조하였다. 알로에 아보레센스 추출물은 0.22 μm syringe filter (whatman, UK)를 통해 제균한 뒤 FDPCG Medium에 희석하여 처리하였다.In the present invention, Human Follicle Dermal Papilla Cell (HFDPC, Promocell) was used to confirm the extract's protective effect on dermal papilla cells against ultraviolet rays, and a cytotoxicity test was conducted prior to the experiment. As a cell culture medium, Follicle Dermal Papilla Cell Growth Medium (FDPCG Medium, Promocell) was used, and Follicle Dermal Papilla Cell Growth Medium KIT (final concentration Fetal Calf Serum 0.04 ml/ml, Bovine Pituitary Extract 0.004 ml/ml, Basic Fibroblast Growth Factor (recombinant human) 1 ng/ml, Insulin (recombinant human) 5 μg/m) was added. Aloe arborescens extract was sterilized through a 0.22 μm syringe filter (whatman, UK) and then diluted in FDPCG Medium.
먼저 HFDPC를 상기 배지를 이용해 전배양한 뒤, trypsin를 이용해 dish에서 떼어낸 뒤, 96 well plate에 well 당 1.0×105 cell을 주입하여 24시간 배양하였다. 세포의 부착이 확인되면 상층액을 제거한 뒤 시료가 포함된 FDPCG Medium을 100 μg/mL를 기준으로 다양한 농도로 처리한 뒤 24시간 동안 배양하였다. 그 후 자외선 20 mJ/cm2를 조사한 다음 2',7'-dichlorofluorescein diacetate(DCFDA)-Cellular Reactive Oxygen Species Detection Assay Kit(Abcam)를 이용하여 ROS를 측정하였다. DCFDA를 20 μM 농도로 함유하는 FDPCG Medium를 100 μL 주입하여 45 min 동안 세포를 염색하고 상층액을 제거한 뒤, Supplemented Buffer 100 μL를 첨가하여 이를 ELISA reader를 이용하여 excitation 485 nm, emission 530 nm에서 형광도를 측정하여 대조군에 대한 비율을 구하였다.First, HFDPC was pre-cultured using the above medium, then removed from the dish using trypsin, and then 1.0×10 5 cells per well were injected into a 96 well plate and cultured for 24 hours. When cell attachment was confirmed, the supernatant was removed, and FDPCG Medium containing the sample was treated with various concentrations based on 100 μg/mL and cultured for 24 hours. Afterwards, 20 mJ/cm 2 of ultraviolet light was irradiated and ROS was measured using 2',7'-dichlorofluorescein diacetate (DCFDA)-Cellular Reactive Oxygen Species Detection Assay Kit (Abcam). 100 μL of FDPCG Medium containing DCFDA at a concentration of 20 μM was injected to stain the cells for 45 min, the supernatant was removed, and 100 μL of Supplemented Buffer was added and fluorescently detected using an ELISA reader at excitation 485 nm and emission 530 nm. The degree was measured and the ratio relative to the control group was obtained.
자외선은 모공 모유두세포의 ROS 생성을 유도하여, 세포 사멸 및 탈모를 유발할 수 있으며, 본 발명에서는 모유두세포에 자외선을 조사하여 세포 사멸 및 ROS 생성 억제 효과를 확인하였다.Ultraviolet rays can induce ROS production in hair papilla cells, causing cell death and hair loss. In the present invention, the effect of suppressing cell death and ROS production was confirmed by irradiating ultraviolet rays to dermal papilla cells.
HFDPC가 자외선을 받을 경우 세포 손상에 의해 항산화 작용에 문제가 발생하며 활성산소가 생성된다. 이렇게 생긴 활성산소는 세포 사멸의 원인이 된다.When HFDPC is exposed to ultraviolet rays, cell damage causes problems with its antioxidant function and free radicals are generated. The reactive oxygen species formed in this way cause cell death.
[표 11] 및 도 10에 나타낸 바와 같이, 알로에 아보레센스 추출물의 발효 전과 발효 후의 자외선에 의한 활성산소 보호 효과 즉, HFDPC 내의 ROS 억제효과를 살펴보면, 발효 전과 발효 후 모든 농도 범위에서 UV를 조사하였을 때, ROS의 기준점인 100%에 비해 낮은 ROS를 보였으며, 이는 알로에 아보레센스 추출물이 자외선에 의한 ROS의 생성을 억제한다는 것을 보여준다. 이때 양측을 비교할 경우 모든 농도에서 알로에 아보레센스 발효 추출물을 처리한 세포가 더 낮은 ROS 생성량을 보여 발효를 통해 보호효과를 높인 것으로 예상된다.As shown in [Table 11] and Figure 10, looking at the active oxygen protection effect by ultraviolet rays before and after fermentation of the Aloe arborescens extract, that is, the ROS inhibition effect in HFDPC, UV was irradiated in all concentration ranges before and after fermentation. At this time, ROS was lower than the ROS standard of 100%, showing that Aloe arborescens extract inhibits the production of ROS by ultraviolet rays. At this time, when comparing the two sides, cells treated with fermented Aloe arborescens extract at all concentrations showed lower ROS production, which is expected to increase the protective effect through fermentation.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 통상의 기술자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.As the specific parts of the present invention have been described in detail above, it is clear to those skilled in the art that these specific techniques are merely preferred implementation examples and do not limit the scope of the present invention. Terms or words used in this specification and claims should not be construed as limited to their common or dictionary meanings, and the inventor may appropriately define the concept of terms in order to explain his or her invention in the best way. It must be interpreted with meaning and concept consistent with the technical idea of the present invention based on the principle that it is. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (7)
상기 조성물은 자외선에 의한 모유두 세포 및 섬유아세포의 사멸을 방지하는 효과를 나타내는 것을 특징으로 하는 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물.According to paragraph 1,
The composition is a composition for improving hair loss or scalp irritation caused by ultraviolet rays containing fermented extract of Aloe arborescens as an active ingredient, which has the effect of preventing the death of dermal papilla cells and fibroblasts caused by ultraviolet rays.
상기 조성물은 자외선에 의한 세포 사멸 및 ROS 생성을 억제하는 효과를 나타내는 것을 특징으로 하는 알로에 아보레센스 발효 추출물을 유효성분으로 함유하는 자외선으로 인한 탈모 또는 두피 자극 개선용 조성물.According to paragraph 1,
The composition is a composition for improving hair loss or scalp irritation caused by ultraviolet rays, containing as an active ingredient a fermented extract of Aloe arborescens, which has the effect of suppressing cell death and ROS production caused by ultraviolet rays.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230194438A KR102653830B1 (en) | 2023-12-28 | 2023-12-28 | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230194438A KR102653830B1 (en) | 2023-12-28 | 2023-12-28 | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102653830B1 true KR102653830B1 (en) | 2024-04-02 |
Family
ID=90714551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230194438A KR102653830B1 (en) | 2023-12-28 | 2023-12-28 | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102653830B1 (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09241132A (en) * | 1996-03-04 | 1997-09-16 | Yoichiro Kumashiro | Aloe hair-growing solution or aloe hair-growing paste |
JPH1135431A (en) * | 1997-07-24 | 1999-02-09 | Hideo Asada | Extraction of aloe medicinal ingredient and hair grower |
KR102005777B1 (en) * | 2017-12-11 | 2019-07-31 | 육상조 | Composition for stimulating hair growth and preventing depilation, and cosmetics comprising the same |
KR102100333B1 (en) | 2018-10-23 | 2020-04-13 | 창원대학교 산학협력단 | Composition for preventing hair loss and promoting hair growth containing mixed extract of Salvia plebia, Polygala tenuifolia and Aloe Barbadensis |
KR20210056473A (en) * | 2019-11-08 | 2021-05-20 | 구스타 주식회사 | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Complex Extracts of Beet, Red Onion, and Purple Sweet Potato as an Active Ingredient |
KR20210080268A (en) * | 2019-12-20 | 2021-06-30 | (주)뷰티언스 | manufacturing method for cosmetic composition containing fermented aloe as an active ingredient |
KR20210079820A (en) * | 2019-12-20 | 2021-06-30 | (주)뷰티언스 | Cosmetic composition containing aloe aborescens extract as an active ingredient, manufacturing method for the same |
KR20220136107A (en) | 2021-03-29 | 2022-10-07 | (주)케비젠 | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same |
JP2022164406A (en) * | 2021-04-16 | 2022-10-27 | 株式会社ヤクルト本社 | Cleansing cosmetic and method for producing the same |
KR102559639B1 (en) * | 2023-04-10 | 2023-07-26 | 주식회사 더하노이 | Shampoo composition and preparation method thereof |
KR20230112789A (en) * | 2022-01-20 | 2023-07-28 | (주)뷰티언스 | Cosmetic compositions including Aloe leaf skin extracts fermented by lactic acid bacteria |
-
2023
- 2023-12-28 KR KR1020230194438A patent/KR102653830B1/en active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09241132A (en) * | 1996-03-04 | 1997-09-16 | Yoichiro Kumashiro | Aloe hair-growing solution or aloe hair-growing paste |
JPH1135431A (en) * | 1997-07-24 | 1999-02-09 | Hideo Asada | Extraction of aloe medicinal ingredient and hair grower |
KR102005777B1 (en) * | 2017-12-11 | 2019-07-31 | 육상조 | Composition for stimulating hair growth and preventing depilation, and cosmetics comprising the same |
KR102100333B1 (en) | 2018-10-23 | 2020-04-13 | 창원대학교 산학협력단 | Composition for preventing hair loss and promoting hair growth containing mixed extract of Salvia plebia, Polygala tenuifolia and Aloe Barbadensis |
KR20210056473A (en) * | 2019-11-08 | 2021-05-20 | 구스타 주식회사 | Composition for Preventing or Treating Hair Loss or Stimulating Hair Sprouting or Hair Growth Comprising Complex Extracts of Beet, Red Onion, and Purple Sweet Potato as an Active Ingredient |
KR20210080268A (en) * | 2019-12-20 | 2021-06-30 | (주)뷰티언스 | manufacturing method for cosmetic composition containing fermented aloe as an active ingredient |
KR20210079820A (en) * | 2019-12-20 | 2021-06-30 | (주)뷰티언스 | Cosmetic composition containing aloe aborescens extract as an active ingredient, manufacturing method for the same |
KR102344995B1 (en) | 2019-12-20 | 2021-12-29 | (주)뷰티언스 | Cosmetic composition containing aloe aborescens extract as an active ingredient, manufacturing method for the same |
KR20220136107A (en) | 2021-03-29 | 2022-10-07 | (주)케비젠 | Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same |
JP2022164406A (en) * | 2021-04-16 | 2022-10-27 | 株式会社ヤクルト本社 | Cleansing cosmetic and method for producing the same |
KR20230112789A (en) * | 2022-01-20 | 2023-07-28 | (주)뷰티언스 | Cosmetic compositions including Aloe leaf skin extracts fermented by lactic acid bacteria |
KR102559639B1 (en) * | 2023-04-10 | 2023-07-26 | 주식회사 더하노이 | Shampoo composition and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
Indian Journal of Natural Products and Resources, (2011) Vol. 2(2), pp. 179-183 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101824770B1 (en) | Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract | |
KR20140126892A (en) | External composition for skin containing Ginsenoside Rg3 | |
KR20140114239A (en) | The skin whitening cosmetic composition | |
KR102373899B1 (en) | Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient | |
KR102653830B1 (en) | Composition for improving hair loss and scalp irritation caused by ultraviolet rays containing fermented Aloe aborescens extract | |
KR100971655B1 (en) | Cosmetic composition with the anti-oxidant, anti-inflammatory and anti-wrinkled effect | |
KR20200098153A (en) | Composition for preventing or improving of skin wrinkle or skin photo-aging comprising fermented extract of Dendropanax morbifera and purple sweet potato as an active ingredient | |
KR102025634B1 (en) | Cosmetic composition containing gastrodiae elata for prevention of skin-aging | |
KR20160096272A (en) | A skin-care agent containing Mesembryanthemum crystallinum L. fermentation extract using yeast | |
KR101781111B1 (en) | Cosmetic composition containing extracts of magnolia officinalis, buplerum falcatum and/or schizonepeta tenuifolia | |
KR20080104671A (en) | The cosmetic composition with the anti-aging effect using supercritical fluid extraction method | |
KR20140081137A (en) | A skin-care agent containig Morchella esculenta fruit body extract or Morchella esculenta mycelium extract | |
KR20170089093A (en) | A cosmetic composition for antioxidating comprising extracts of eisenia bycyclis, gallnut and rhubarb | |
KR100820010B1 (en) | Anti-oxidant herb cosmetic composition containing ravendor, horsemint, freesia, peppermint, camomile and rosemary for protecting skin and hair skin and method for preparing the same | |
CN108721179B (en) | Plant extract composition with whitening effect, preparation method and application | |
KR101862314B1 (en) | Composition for improvement effect vitality of skin and hair, manufacturing process for the same | |
KR20170078899A (en) | Cosmetic composition containing natural complex fermented extracts | |
KR20090026826A (en) | Cosmetic composition containing plant extracts with the antioxidant effect | |
Jeong et al. | Fermented Onions Extract Inhibits Tyrosinase and Collagenase-1 Activities as a Potential New Anti–Photoaging Agent | |
KR20200021180A (en) | Cosmetic composition for improving skin wrinkle or skin aging comprising mixture extract of Chrysanthemum morfiolium, Aloe vera, and Hedera Helix | |
KR20140081982A (en) | A skin-care agent containig Lyophyllum ulmarium fruit body extract or Lyophyllum ulmarium mycelium extract | |
KR20140131027A (en) | Skin external composition containing ginsenoside Rh4 | |
KR102428422B1 (en) | Method for preparing complex extract containing elder flower, chamomile flower, and calendula flower with antioxidant and whitening activity | |
KR102601762B1 (en) | Cosmetic composition for anti-oxidant or improving skin regeneration comprising caviar extract and vitamin c or derivative thereof as effective ingredients | |
KR101274606B1 (en) | Cosmetic composition containing the extract of jujube extracted with high pressure |